Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7895-7902

  Means, Robert E ^a   Greenough, Thomas ^b   Desrosiers, Ronald C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

EID: 0030775635     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7895-7902.1997     Document Type: Article

References (68)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrom associated retrovirus in human and nonhuman cells transfected with a infectious molecular clone. J. Virol. 59:284-291.
2. Akerblom, L., J. Hinkula, P.-A. Broliden, B. Makitalo, T. Fridberger, Rosen, M. Villacres-Eriksson, B. Morein, and B. Wahren. 1990. Neutralization cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp13 AIDS 4:953-960.
3. Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystro and E. M. Fenyö. 1990. Rapid development of isolate-specific neutralization antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112.
4. Albert, J., E. Björling, A. von Gegerfelt, G. Scarlatti, Y.-J. Zhang, E.M. Fenyo, and R. Thorstensson. 1993. Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays. AIDS Res. Hum. Retrovirus 9:501-504.
5. Benichou, S., R. Legrand, N. Nakagawa, T. Faure, F. Traincard, G. Vogt, Dormont, P. Tiollais, M.-P. Kieny, and P. Madaule. 1992. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 8:1165-1170.
6. Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. R. Cullen. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1-10.
7. Berkower, I., D. Murphy, C. C. Smith, and G. E. Smith. 1991. A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120. J. Virol. 65:5983-5990.
8. Björling, E., K. Broliden, D. Bernardi, G. Utter, R. Thorstensson, F. Chiodi, and E. Norrby. 1991. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc. Natl. Acad. Sci. USA 88:6082-6086.
9. Björling, E., G. Scarlatte, A. von Gegerfelt, J. Albert, G. Biberfeld, F. Chodi, E. Norrby, and E. M. Fenyo. 1993. Autologous neutralizing antibodies prevail in HIV-2 but not HIV-1 infection. Virology 193:528-530.
10. Boeri, E., A. Giri, F. Lillo, G. Ferrari, O. E. Varnier, A. Ferro, S. Sabbatani, W. C. Saxinger, and G. Franchini. 1992. In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J. Virol. 66:4546-4550.
11. Bronstejn, I., J. J. Fortin, J. C. Voyta, R.-R. Juo, B. Edwards, C. E. M. Olesen, N. Lijam, and L. J. Kricka. 1994. Chemiluminescent reporter gene assays: sensitive detection of the GUS and SEAP gene products. BioTechniques 17:172-177.
12. Buchbinder, S. P., M. H. Katz, N. A. Hessol, P. M. O'Malley, and S. D. Holmberg. 1994. Long-term HIV-1 infection without immunologic progression. AIDS 8:1123-1127.
13. Burns, D. P. W., C. Collignon, and R. C. Desrosiers. 1993. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67:4104-4113.
14. Burns, D. P. W., and R. C. Desrosiers. 1992. A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res. Hum. Retroviruses 8:1189-1192.
15. Burns, D. P. W., and R. C. Desrosiers. 1994. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr. Top. Microbiol. Immunol. 188:155-186.
16. Cullen, B., and M. Malim. 1992. Secreted placental alkaline phosphatase as a cukaryotic reporter gene. Methods Enzymol. 152:362-368.
17. Daniel, M. D., R. C. Desrosiers, N. L. Letvin, N. W. King, D. K. Schmidt, P. Sehgal, and R. D. Hunt. 1987. Simian models for AIDS. J. Cancer Detect. Prev. 1:501-507.
18. Daniel, M. D., N. L. Letvin, N. W. King, M. Kannagi, P. K. Sehgal, R. D. Hunt, P. J. Kanki, M. Essex, and R. C. Desrosiers. 1985. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201-1204.
19. Daniel, M. D., N. L. Letvin, P. K. Sehgal, G. Hunsmann, D. K. Schmidt, N. W. King, and R. C. Desrosiers. 1987. Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J. Gen. Virol. 68:3183-3189.
20. Desrosiers, R. C., and D. J. Ringler. 1989. The use of simian immunodeficiency viruses for AIDS research. Intervirology 30:301-312.
21. D'Souza, M. P., P. Durda, C. V. Hanson, and G. Milman. 1991. Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. AIDS 5:1061-1070.
22. D'Souza, M. P., K. A. Kent, C. Thiriart, C. Collignon, G. Milman, and Collaborating Investigators. 1993. International collaboration comparing neutralization and binding assays for monoclonal antibodies to simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:415-422.
23. Emerman, M., M. Guyader, L. Montagnier, D. Baltimore, and M. A. Muesing. 1987. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J. 6:3755-3760.
24. Goldstein, S., B. Hauge, D. Montefiori, and V. Hirsch. 1995. A macaque adherent cell line that expresses human CD4 is susceptible to SIV: utility for assessing neutralizing antibody. J. Virol. Methods 53:139-148.
25. Goudsmit, J., C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478-4482.
26. Haigwood, N. L., J. R. Shuster, G. K. Moore, H. Lee, P. V. Skiles, K. W. Higgins, P. J. Barr, C. George-Nascimento, and K. S. Steimer. 1990. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses 6:855-869.
27. Harrowe, G., and C. Cheng-Mayer. 1995. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210:490-494.
28. Helseth, E., M. Kowalski, D. Gabuzda, U. Olshevsky, W. Haseltine, and J. Sodroski. 1990. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64:2416-2420.
29. Ho, D. D., M. S. C. Fung, Y. Cao, X. L. Li, C. Sun, T. W. Chang, and N.-C. Sun. 1991. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization identified hy a monoclonal antibody. Proc. Natl. Acad. Sci. USA 88:8949-8952.
30. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N.-C. Sun, and J. E. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
31. Ho, D. D., M. G. Sarngadharan, M. S. Hirsch, R. T. Schooley, T. R. Rota, R. C. Kennedy, T. C. Chanh, and V. L. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61:2024-2028.
32. Hsu, M.-C., A. D. Schutt, M. Holly, L. W. Slice, M. I. Sherman, D. D. Richman, M. J. Potash, and D. J. Volsky. 1991. Inhibition of HIV replication in acute and chronic infections in vitro by a tat antagonist. Science 254:1799-1802.
33. Javaherian, K., A. J. Langlois, D. C. Montefiori, K. A. Kent, K. A. Ryan, P. D. Wyman, E. J. Stott, D. P. Bolognesi, M. Murphey-Corb, and G. J. LaRosa. 1994. Studies on the conformation-dependent neutralizing epitopes of the simian immunodeficiency virus envelope protein. J. Virol. 68:2624-2631.
34. Javaherian, K., A. J. Langlois, S. Schmidt, M. Kaufmann, N. Gates, J. P. M. Langedijk, R. H. Meloen, R. C. Desrosiers, D. P. W. Burns, D. P. Bolognesi, G. J. LaRosa, and S. D. Putney. 1992. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:1418-1422.
35. Kent, K. A., E. Rud, T. Corcoran, C. Powell, C. Thiriart, C. Collignon, and E. J. Stott. 1992. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8:1147-1151.
36. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
37. Kodama, T., D. P. W. Burns, D. P. Silva, F. diMarzo Veronese, and R. C. Desrosiers. 1991. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency vims. J. Virol. 65:2010-2018.
38. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
39. Langlois, A. J., K. J. Weinhold, T. J. Matthews, and D. P. Bolognesi. 1991. In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVmac251. AIDS Res. Hum. Retroviruses 7:713-720.
40. Lewis, M. G., S. Bellah, K. McKinnon, J. Yalley-Ogunro, P. M. Zack, W. R. Elkins, R. C. Desrosiers, and G. E. Eddy. 1994. Titration and characterization of two rhesus derived SIVmac challenge stocks. AIDS Res. Hum. Retroviruses 10:213-220.
41. Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 tat protein trans-activates transcription in vitro. Cell 63:791-802.
42. Mascola, J. R., and D. S. Burke. 1993. Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasma. AIDS Res. Hum. Retroviruses 9:1173-1174.
43. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
44. Matsushita, S., S. Matsumi, K. Yoshimura, T. Morikita, T. Murakami, and K. Takatsuki. 1995. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120. J. Virol. 69:3333-3340.
45. Matsushita, S., M. Robert-Guroff, J. R. Rusche, A. Koito, T. Hatori, H. Haskino, K. Javaherian, K. Takatsuki, and S. D. Putney. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralization epitope. J. Virol. 62:2107-2114.
46. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
47. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
48. Montefiori, D., T. W. Baba, A. Li, M. Bilska, and R. M. Ruprecht. 1996. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239(delta)3 in adult and infant rhesus monkeys. J. Immunol. 157:5528-5538.
49. Montefiori, D. C., W. E. Robinson, S. S. Schuffman, and W. M. Mitchell. 1988. Evaluation of antiviral and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Virol. 26:231-235.
50. Moore, J. P., L. C. Burkley, R. I. Connor, Y. Cao, R. Tizard, D. D. Ho, and R. A. Fisher. 1997. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4. AIDS Res. Hum. Retroviruses 9:529-539.
51. Moore, J. P., Y. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
52. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Interand intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
53. Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
54. Moore, J. P., and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9:S117-S136.
55. Naidu, Y. M., H. W. Kestler, III, Y. Li, C. V. Butler, D. P. Silva, D. K. Schmidt, C. D. Troup, P. K. Sehgal, P. Sonigo, M. D. Daniel, and R. C. Desrosiers. 1988. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62:4691-4696.
56. Nara, P. L., W. C. Hatch, N. M. Dunlop, W. G. Robey, L. O. Arthur, M. A. Gonda, and P. J. Fischinger. 1987. Simple, rapid, quantitative, syncytiaforming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3:283-302.
57. Orloff, S. L., C. I. Bandea, M. S. Kennedy, G. P. Allaway, P. J. Maddon, and J. S. McDougal. 1995. Increase in sensitivity to soluble CD4 by primary HIV type 1 isolates after passage through C8166 cells: association with sequence differences in the first constant (C1) region of glycoprotein 120. AIDS Res. Hum. Retroviruses 11:335-342.
58. Robert-Guroff, M., K. Aldrich, R. Muldoon, T. L. Stern, G. P. Bansal, T. J. Matthews, P. D. Markham, R. C. Gallo, and G. Franchini. 1992. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol. 66:3602-3608.
59. Rocancourt, D., C. Bonnerot, H. Jouin, M. Emerman, and J. F. Nicolas. 1990. Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells. J. Virol. 64:2660-2668.
60. Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fischinger, D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA 85:3198-3202.
61. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
62. Terwilliger, E. F., B. Godin, J. G. Sodroski, and W. A. Haseltine. 1989. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc. Natl. Acad. Sci. USA 86:3857-3861.
63. Thali, M., U. Olshevsky, C. Furman, D. Gabuzoa, M. Posner, and J. Sodroski. 1991. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65:6188-6193.
64. Thorstensson, R., L. Walther, P. Putkonen, J. Albert, and G. Biberfeld. 1990. A capture enzyme immunoassay for detection of H1V-2/SLV antigen. J. Acquired Immune Defic. Syndr. 4:374-379.
65. Tong-Starkensen, S. E., A. Baur, X. B. Lu, and B. M. Peterlin. 1993. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs. Virology 195:826-830.
66. Wrin, T., T. J. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberger. 1995. Adaptation of persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-18.
67. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
68. Zolla-Pazner, S., and S. Sharpe. 1995. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates. AIDS Res. Hum. Retroviruses 11:1449-1458.